Approval of hospital for the purpose of sub-clause (b) of clause (ii) of the proviso to clause (viii) of sub-section (2) of section 17 of the Income-tax Act, 1961 - M/s Divyajyoti Eye & Healthcare Pvt. Ltd.,[PAN : AAFCD9479C], C-65, Hanuman Nagar, Patna-800020
📋
Contents
Cases Cited
Referred In
Notifications
Circulars
Forms
Manuals
Acts
Rules & Regulations
Case Laws New
Ref Provisions New
Plus +
Source NTF
Summary
Similar
Note
Bookmark
Share
✓ Copied successfully !
Print
Print Options
For full text, please login
Login to TaxTMI
Verification Pending
The Email Id has not been verified. Click on the link we have sent on
Hospital approval under section 17: employer-paid treatment costs at approved hospital not treated as a perquisite for specified diseases. Approval granted to M/s Divyajyoti Eye & Healthcare Pvt. Ltd. as an approved hospital under the proviso to section 17 read with Rule 3A(1) & 3A(2). Employer payments for employee or family medical treatment at the hospital for diseases listed in Rule 3A(2)(e) shall not be treated as a perquisite for sections 15-17, and the employer need not deduct tax at source under section 192. Approval is effective from issuance, valid for three years, and subject to compliance, modification, or withdrawal for misrepresentation or noncompliance.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Hospital approval under section 17: employer-paid treatment costs at approved hospital not treated as a perquisite for specified diseases.
Approval granted to M/s Divyajyoti Eye & Healthcare Pvt. Ltd. as an approved hospital under the proviso to section 17 read with Rule 3A(1) & 3A(2). Employer payments for employee or family medical treatment at the hospital for diseases listed in Rule 3A(2)(e) shall not be treated as a perquisite for sections 15-17, and the employer need not deduct tax at source under section 192. Approval is effective from issuance, valid for three years, and subject to compliance, modification, or withdrawal for misrepresentation or noncompliance.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.